Clinical Trials Browser

Phase 2 × UNKNOWN × Lymphoma, T-Cell, Peripheral × Clear all

NCT02404571 2016-07-26

GDP in Frontline Chemotherapy for Patients With PTCL-NOS

Phase 2 Unknown

Lymphoma, T-Cell, Peripheral